Renal Business Today - Kidney

Neoral equivalent to tacrolimus, study says

BOSTON-- Neoral (cyclosporine) and tacrolimus have equivalent efficacy in preventing organ rejection in kidney transplant patients, but those treated with Neoral had a significantly lower incidence of new-onset diabetes, according to a recent study presented today at the ...More

August 7, 2006

Posted in News, Clinical & Pharma, Practice Management

AKF, Genzyme launch Renagel assistance program

CAMBRIDGE--The American Kidney Fund and Genzyme Corp. have teamed up to launch a program that will provide Renagel to Medicare patients who can't afford co-payments for the phosphorus drug. ...More

July 31, 2006

Posted in News, Business, Clinical & Pharma, Government & Regulation, Practice Management

Primary-care docs failing to diagnose kidney disease

BALTIMORE--A large portion of primary-care doctors in the United States are failing to diagnose and refer patients with chronic kidney disease, according to a Johns Hopkins University study. ...More

July 31, 2006

Posted in News, Clinical & Pharma, Practice Management

Johns Hopkins to launch study of kidney disease in children

--Johns Hopkins researchers are launching, what they call, the largest study ever conducted to study kidney disease in children. ...More

July 27, 2006

Posted in News, Clinical & Pharma, Practice Management

AAKP reached more than 1 million patients, families last year

TAMPA , Fla.--The American Association of Kidney Patients helped more than 1 million patients and their families and friends with health education, information and resources during the 2005-06 fiscal year, the patient organization said today. ...More

July 24, 2006

Posted in News, Business, Clinical & Pharma, Practice Management

Genzyme to make kidney transplant drug in Ireland

CAMBRIDGE, Mass.--The U.S. Food and Drug Administration has approved Genzyme Corp.'s plans to manufacture the kidney transplant drug Thymoglobulin at its Waterford, Ireland, manufacturing plant, the company said Monday. ...More

July 24, 2006

Posted in News, Business, Clinical & Pharma, Government & Regulation

Roxane recalls kidney transplant drug

COLUMBUS, Ohio--Roxane Laboratories Inc. has recalled a single manufacturing lot of the kidney transplant drug Azathioprine because the company found Methotrexate tablets in one bottle. ...More

July 13, 2006

Posted in News, Clinical & Pharma, Government & Regulation, Practice Management

ESRD risk higher in U.S. than Europe

TRONDHEIN, Norway--The higher rate of end-stage renal disease in the United States when compared to European countries reflects a more severe risk of late-stage kidney disease and not a larger number of Americans in the early stages of chronic kidney disease, according to a ...More

June 29, 2006

Posted in News, Business, Clinical & Pharma, Government & Regulation, Practice Management

RenaMed receives $2.3 million loan

LINCOLN, R.I.--RenaMed Biologics Inc. said today it has received a $2.3 million loan from a Massachusetts organization that will be used to expand the company's commercial operations ...More

June 19, 2006

Posted in News, Business, Clinical & Pharma, Government & Regulation

Spectrum recalls kidney transplant drug

GARDENA, Calif.—Spectrum Laboratory Products Inc. has voluntarily recalled all lots of its transplant drug tacrolimus after learning some containers might be less potent than expected, according to a company spokesman. ...More

May 17, 2006

Posted in News, Clinical & Pharma, Government & Regulation, Practice Management

Computers & Software	Consulting, Management...
Equipment & Services	Hemodialysis Supplies
Patient Services	More Options...

Kidney

Video Snapshot

Galleries

RBT Poll

Most Popular Articles

Buyer's Guide

Resources

Free Email Updates

featured links

First Name	Last Name
E-Mail